Related Experiment Video
Updated: Jul 18, 2026

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
Management of chronic lymphocytic leukemia in Canada during the coronavirus pandemic
L H Sehn1, P Kuruvilla2, A Christofides3
1BC Cancer, Centre for Lymphoid Cancer, and University of British Columbia, Vancouver, BC.
Insights
The COVID-19 pandemic necessitates updated chronic lymphocytic leukemia (CLL) treatment guidelines. This summary reviews American Society of Hematology (ASH) recommendations for managing CLL patients during the pandemic in Canada.
Area of Science:
- Hematology
- Infectious Diseases
- Oncology
Background:
- The COVID-19 pandemic has significantly impacted clinical practices for patients with chronic lymphocytic leukemia (CLL).
- Hematologists require updated guidance for managing CLL patients amidst the global health crisis.
Purpose of the Study:
- To summarize the American Society of Hematology (ASH) recommendations for CLL patient care during the COVID-19 pandemic.
- To discuss the applicability of these ASH guidelines within the Canadian healthcare context.
Main Methods:
- Review and synthesis of published ASH recommendations.
- Analysis of the relevance and implementation of these recommendations for Canadian CLL patient management.
Main Results:
- ASH provides comprehensive guidance on COVID-19 testing, CLL treatment initiation and selection, immunoglobulin therapy, monitoring, and managing co-infected patients.
- The recommendations offer a framework for adapting CLL care during the pandemic.
Conclusions:
- ASH guidelines offer crucial direction for managing chronic lymphocytic leukemia patients during the COVID-19 pandemic.
- These recommendations are adaptable for Canadian clinicians to ensure optimal patient care and safety.
Abstract:
The emergence of the covid-19 disease pandemic caused by the 2019 novel coronavirus has required a re-evaluation of treatment practices for clinicians caring for patients with chronic lymphocytic leukemia (cll). The American Society for Hematology (ash) has provided a series of recommendations for the treatment of patients with cll during the pandemic, covering a range of topics, including testing for covid-19, cll treatment initiation and selection, use of immunoglobulin therapy, in-person monitoring, and treatment of patients with cll and covid-19. We summarize the ash recommendations and discuss their applicability as guidelines for the treatment of cll during the covid-19 pandemic in Canada.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Kidney Disease IV: Nursing Management

